Gut viruses in inflammatory bowel disease treatment
Part of Digestive system clinical trials.
This study looks at viruses living in your gut (the 'virome') to better understand and potentially improve treatment for inflammatory bowel disease (IBD). It involves collecting samples and information to see how these viruses relate to your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis, Crohn's disease, or PSC-IBD for at least 6 months.
- You are 18 years old or older.
- Your IBD treatment has been stable for the past 3 months.
- Your diet, exercise, and sleep habits have been stable for the past month.
- You have not taken antibiotics in the past 3 months.
- You are not pregnant or breastfeeding, and do not have other major health conditions that affect gut bacteria (like diabetes, other autoimmune diseases, cancer, or severe obesity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study looks at how the bacteria living in your gut affect your body's energy use. It includes both healthy volunteers and people with inactive Crohn's disease or ulcerative colitis.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.